$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

$sfes Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000008611518000087 Filed on October 25, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.600M	$3.500M	$3.800M
YoY Change	-33.33%	-7.89%	-19.15%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.600M	$3.500M	$3.800M
YoY Change	-35.0%	-7.89%	-19.15%
Operating Profit	-$2.618M	-$3.516M	-$3.758M
YoY Change	-33.55%	-6.44%	-19.82%
Interest Expense	-$13.80M	$36.70M	-$14.90M
YoY Change	-6.76%	-346.31%	-12.35%
% of Operating Profit
Other Income/Expense, Net	-$193.0K	-$1.078M	-$379.0K
YoY Change	60.83%	184.43%	-84.24%
Pretax Income	-$16.62M	$32.06M	-$18.65M
YoY Change	-11.24%	-271.9%	-22.57%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$16.62M	$32.06M	-$18.65M
YoY Change	-11.24%	-271.9%	-22.57%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.81	$1.56	-$0.91
Diluted Earnings Per Share	-$0.81	$1.56	-$0.91
COMMON SHARES
Basic Shares Outstanding	20.65M shares	20.56M shares	20.46M shares
Diluted Shares Outstanding		20.56M shares	20.46M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.70M	$69.60M	$39.72M
YoY Change	80.99%	75.24%	-40.1%
Cash & Equivalents	$7.703M	$44.50M	$34.32M
Short-Term Investments	$38.00M	$25.10M	$5.400M
Other Short-Term Assets	$1.100M	$2.100M	$3.700M
YoY Change	-76.09%	-43.24%	94.74%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$46.74M	$73.04M	$47.06M
YoY Change	39.06%	55.21%	-31.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$808.0K	$1.293M	$1.626M
YoY Change	-46.6%	-20.48%	-16.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$64.49M	$71.69M	$114.3M
YoY Change	-40.34%	-37.29%	-24.74%
Other Assets	$2.609M	$316.0K	$316.0K
YoY Change	725.63%	0.0%	6.76%
Total Long-Term Assets	$99.00M	$105.3M	$147.2M
YoY Change	-30.7%	-28.47%	-20.64%
TOTAL ASSETS
Total Short-Term Assets	$46.74M	$73.04M	$47.06M
Total Long-Term Assets	$99.00M	$105.3M	$147.2M
Total Assets	$145.7M	$178.4M	$194.3M
YoY Change	-17.41%	-8.2%	-23.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$165.0K	$17.00K	$171.0K
YoY Change	6.45%	-90.06%	55.45%
Accrued Expenses	$2.182M	$2.213M	$2.495M
YoY Change	17.88%	-11.3%	-20.44%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$22.10M	$40.10M
YoY Change	-100.0%	-44.89%
Total Short-Term Liabilities	$32.94M	$28.34M	$45.66M
YoY Change	-28.1%	-37.93%	601.89%
LONG-TERM LIABILITIES
Long-Term Debt	$43.00M	$63.40M	$44.90M
YoY Change	-5.08%	41.2%	-13.82%
Other Long-Term Liabilities	$2.804M	$3.106M	$3.504M
YoY Change	-20.68%	-11.36%	-11.22%
Total Long-Term Liabilities	$2.804M	$3.106M	$3.504M
YoY Change	-20.68%	-11.36%	-11.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.94M	$28.34M	$45.66M
Total Long-Term Liabilities	$2.804M	$3.106M	$3.504M
Total Liabilities	$78.76M	$94.84M	$94.07M
YoY Change	-16.81%	0.82%	50.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$731.1M	-$714.5M	-$696.7M
YoY Change	2.18%	2.55%	15.13%
Common Stock	$813.1M	$813.3M	$817.2M
YoY Change	-0.2%	-0.48%	-0.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$15.00M	$15.28M	$20.12M
YoY Change	-13.33%	-24.05%	-14.25%
Treasury Stock Shares	914.0K shares	926.0K shares	1.169M shares
Shareholders Equity	$67.00M	$83.50M	$100.2M
YoY Change
Total Liabilities & Shareholders Equity	$145.7M	$178.4M	$194.3M
YoY Change	-17.41%	-8.2%	-23.43%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	-$16.62M	$32.06M	-$18.65M
YoY Change	-11.24%	-271.9%	-22.57%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$7.400M	-$5.000M	-$4.100M
YoY Change	39.62%	21.95%	24.24%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$12.50M	$23.60M	-$7.000M
YoY Change	52.44%	-437.14%	-32.69%
Cash From Investing Activities	-$12.50M	$23.60M	-$7.000M
YoY Change	52.44%	-437.14%	-32.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-16.50M	0.000	-2.700M
YoY Change	16400.0%	-100.0%	2600.0%
NET CHANGE
Cash From Operating Activities	-7.400M	-5.000M	-4.100M
Cash From Investing Activities	-12.50M	23.60M	-7.000M
Cash From Financing Activities	-16.50M	0.000	-2.700M
Net Change In Cash	-36.40M	18.60M	-13.80M
YoY Change	167.65%	-234.78%	0.0%
FREE CASH FLOW
Cash From Operating Activities	-$7.400M	-$5.000M	-$4.100M
Capital Expenditures			$0.00
Free Cash Flow			-$4.100M
YoY Change			24.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000086115
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20647178	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SAFEGUARD SCIENTIFICS INC
	dei	Trading Symbol TradingSymbol	SFE
CY2018Q3	sfe	Cash Cash Equivalents And Marketable Securities CashCashEquivalentsAndMarketableSecurities	69600000	USD
CY2018Q3	sfe	Debt Instrument Gain Lossfrom Covenant Liability DebtInstrumentGainLossfromCovenantLiability	-2600000	USD
	sfe	Debt Instrument Gain Lossfrom Covenant Liability DebtInstrumentGainLossfromCovenantLiability	-5100000	USD
CY2001Q4	sfe	Future Annual Payment To Chairman And Chief Executive Officer FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer	650000	USD
CY2017Q4	sfe	Lineof Credit Facility Repayment Feature Current LineofCreditFacilityRepaymentFeatureCurrent	0	USD
CY2018Q3	sfe	Lineof Credit Facility Repayment Feature Current LineofCreditFacilityRepaymentFeatureCurrent	5622000	USD
CY2017Q3	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	0	USD
	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	50000	USD
CY2018Q3	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	-14000	USD
	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	67000	USD
CY2017Q3	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	274000	USD
	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	277000	USD
CY2018Q3	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	33000	USD
	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	33000	USD
CY2018Q3	sfe	Partner Companies Not Consolidated In Financial Statements PartnerCompaniesNotConsolidatedInFinancialStatements	22	nonconsolidated_partner_company
CY2018Q1	sfe	Saleof Stock Individual Ownership Percent Maximum SaleofStockIndividualOwnershipPercentMaximum	0.0499
CY2017	sfe	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit	82500000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	155000	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	17000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1851000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2213000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-113000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-13000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	812536000	USD
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	811131000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	853000	USD
CY2017Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	22506000	USD
CY2018Q3	us-gaap	Advances To Affiliate AdvancesToAffiliate	15443000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	560000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	806000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	243000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	853000	USD
CY2017Q4	us-gaap	Assets Assets	176464000	USD
CY2018Q3	us-gaap	Assets Assets	178352000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	33608000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	73041000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20751000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44522000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44500000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28394000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40653000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27087000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44522000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	12259000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	17435000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-18376000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-69517000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	32079000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1094000	USD
CY2017Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	40485000	USD
CY2018Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2017Q4	us-gaap	Cost Method Investments CostMethodInvestments	4096000	USD
CY2018Q3	us-gaap	Cost Method Investments CostMethodInvestments	16571000	USD
CY2017Q3	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	20455000	USD
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	20416000	USD
CY2018Q3	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	20561000	USD
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	20535000	USD
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.42
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.42
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3321000	USD
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4053000	USD
CY2017Q3	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	60836000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	180158000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	21822000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	153387000	USD
CY2017Q3	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-52648000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-148439000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-34885000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-120971000	USD
CY2017Q3	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	91137000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	275154000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	40070000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	234049000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	108089000	USD
CY2018Q3	us-gaap	Equity Method Investments EquityMethodInvestments	71688000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3758000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13191000	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3516000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14253000	USD
CY2017Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	4452000	USD
CY2018Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	25114000	USD
CY2018Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	25100000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18650000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-69844000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	32060000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	994000	USD
CY2017Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12874000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-53373000	USD
CY2018Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	39246000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	27452000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0	shares
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0	shares
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0	shares
CY2017Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	2643000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	5953000	USD
CY2018Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	3310000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	9422000	USD
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1004000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2892000	USD
CY2018Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	718000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2182000	USD
CY2017Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	134691000	USD
CY2018Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	103702000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	94668000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	94843000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	176464000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	178352000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	45812000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	28338000	USD
CY2017Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2018Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	16433000	USD
CY2017Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	45321000	USD
CY2018Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	63399000	USD
CY2018Q3	us-gaap	Marketable Securities MarketableSecurities	25100000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29686000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8486000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1912000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	44570000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15515000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18649000	USD
CY2017Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	0	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	0	USD
CY2018Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	0	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	0	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3758000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13191000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3516000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14253000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	316000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	316000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	100000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3535000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3106000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-379000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-219000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1078000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4965000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	16933000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	12098000	USD
CY2018Q3	us-gaap	Payments For Restructuring PaymentsForRestructuring	1000000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	1500000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5696000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2252000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	175000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	234000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	11851000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3250000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	24858000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4644000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2098000	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	0	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	10652000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	16604000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	69912000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	50000000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	35000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	10268000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	4211000	USD
CY2018Q3	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	55000000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	-18650000	USD
	us-gaap	Profit Loss ProfitLoss	-69844000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	32060000	USD
	us-gaap	Profit Loss ProfitLoss	994000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1513000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1293000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	14455000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	41000000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6336000	USD
CY2018Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-715476000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-714482000	USD
CY2018Q3	us-gaap	Severance Costs1 SeveranceCosts1	1000000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	3800000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-234000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	81796000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	83509000	USD
CY2017Q4	us-gaap	Trading Securities TradingSecurities	3761000	USD
CY2018Q3	us-gaap	Trading Securities TradingSecurities	1307000	USD
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	999000	shares
CY2018Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	926000	shares
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	17308000	USD
CY2018Q3	us-gaap	Treasury Stock Value TreasuryStockValue	15284000	USD
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20455000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20416000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20561000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20535000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20455000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20416000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20561000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20535000	shares

Files In Submission

Name	View Source	Status
0000086115-18-000087-index-headers.html	Edgar Link	pending
0000086115-18-000087-index.html	Edgar Link	pending
0000086115-18-000087.txt	Edgar Link	pending
0000086115-18-000087-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfe-20180930.xml	Edgar Link	completed
sfe-20180930.xsd	Edgar Link	pending
sfe-20180930_cal.xml	Edgar Link	unprocessable
sfe-20180930_def.xml	Edgar Link	unprocessable
sfe-20180930_lab.xml	Edgar Link	unprocessable
sfe-20180930_pre.xml	Edgar Link	unprocessable
sfe-2018xq3.htm	Edgar Link	pending
sfe-2018xq3xex311.htm	Edgar Link	pending
sfe-2018xq3xex312.htm	Edgar Link	pending
sfe-2018xq3xex321.htm	Edgar Link	pending
sfe-2018xq3xex322.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

2018 Q4 Form 10-Q Financial Statement

#000008611518000087 Filed on October 25, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES SAFEGUARD SCIENTIFICS INC Stock $sfes

2018 Q4 Form 10-Q Financial Statement

#000008611518000087 Filed on October 25, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes